A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process

Br J Haematol. 2010 Mar;148(6):961-3. doi: 10.1111/j.1365-2141.2009.08019.x. Epub 2009 Nov 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Consensus Development Conferences as Topic
  • Drug Resistance*
  • Humans
  • Hydroxyurea / therapeutic use*
  • Polycythemia Vera / drug therapy*
  • Primary Myelofibrosis / drug therapy*
  • Terminology as Topic

Substances

  • Antineoplastic Agents
  • Hydroxyurea